|
| |
 |
| ORIGINAL ARTICLE |
|
| Year : 2014 | Volume
: 18
| Issue : 4 | Page : 502-504 |
|
LDL-cholesterol: Friedewald calculated versus direct measurement-study from a large Indian laboratory database
Subramanian Kannan1, Shriraam Mahadevan2, Bharath Ramji3, Muthukumaran Jayapaul4, V Kumaravel5
1 Consultant, Endocrinology Diabetes and Bariatric Medicine, Narayana Health City, Bangalore, Karnataka, India
2 Endocrine and Speciality Clinic, Chennai, India
3 Assistant Professor Endocrinology, Chettinad Medical College, Chennai, India
4 Consultant Endocrinologist, Arka Center for Hormonal Health, Chennai, India
5 Department of Clinical Endocrinology, Alpha Hospital and Research Centre, Anuppanady, Madurai, Tamil Nadu, India
| Date of Web Publication | 25-Jul-2014 |
Correspondence Address:
Shriraam Mahadevan
Endocrine and Speciality Clinic, 4th Cross Street, R K Nagar, Mandaveli, Chennai 600 028, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2230-8210.137496
 Abstract | | |
Background: Validity of Friedewald formula (FF) in patients with serum triglycerides (TGs) <400 mg/dl is unclear. Materials and Methods: We compared low-density lipoprotein (LDL)-cholesterol calculated by FF to directly measured LDL in a laboratory database of 14,620 lipid profile samples from south India. Results: LDL by FF correlated with directly measured LDL with correlation coefficient of 0.89 with the best correlation seen in TG levels 100-150. Higher level of TG (>200) underestimates the LDL calculated by FF particularly at LDL values <70 mg/dl. On the other hand, LDL is overestimated by FF in more than 70% of cases at LDL levels >130 mg/dl. Conclusion: We suggest repeating the LDL by direct assay techniques particularly in patients with TG >200 and when LDL <70 or >130. This helps in correctly stratifying the coronary artery diseases' (CADs') risk and goals of treatment. Keywords: Friedewald formula, LDL cholesterol, triglyceride
How to cite this article:
Kannan S, Mahadevan S, Ramji B, Jayapaul M, Kumaravel V. LDL-cholesterol: Friedewald calculated versus direct measurement-study from a large Indian laboratory database. Indian J Endocr Metab 2014;18:502-4 |
How to cite this URL:
Kannan S, Mahadevan S, Ramji B, Jayapaul M, Kumaravel V. LDL-cholesterol: Friedewald calculated versus direct measurement-study from a large Indian laboratory database. Indian J Endocr Metab [serial online] 2014 [cited 2021 Jan 22];18:502-4. Available from: https://www.ijem.in/text.asp?2014/18/4/502/137496 |
| Introduction | |  |
Low-density lipoprotein (LDL)-cholesterol, as estimated by the Friedewald formula (FF) in routine patient care, is a central focus of clinical practice guidelines throughout the world. The concentration of LDL is one of the strongest determinants of cardiovascular risk. [1] LDL can be calculated by FF (total cholesterol (TC) minus high-density lipoprotein (HDL)-cholesterol minus triglycerides (TGs)/5 in mg/dl) or measured directly in the laboratory. The FF is not valid for patients with TGs >400 and in patients for type 3 dyslipoproteinemia. [2] A number of studies have studied the impact of TG on the FF. These studies suggest LDL may be underestimated by the FF at low LDL levels and higher TG levels. [3],[4],[5] Limited study results from India have reached discordant conclusions on this topic. A study by Sahu et al., [6] noted that the mean LDL calculated by FF was significantly higher than the direct LDL measurement at TG between 1 and 300 mg/dl. However, the study by Gupta et al., [7] reported underestimation of LDL by FF at all levels of TG (ranging from 45 to 635 mg/dl). LDL was measured using direct homogenous assay (Daiichi Pure Chemicals Co. Ltd, Tokyo, Japan) in both the above studies. Anandaraja et al., [8] noted that FF overestimated LDL in subjects with TG <350 mg/dl (LDL was measured using heparin precipitation method in their study).
Aims
We compared LDL calculated by FF and LDL measured directly, across various strata of TG, HDL, and LDL in a large laboratory database from south India.
Settings and design
Retrospective review of laboratory database.
| Materials And Methods | | |
Outpatient fasting complete lipid profile (including directly measured LDL) for patients >18 years of age performed between January 2006 and February 2007 was included in the study. A total of 14,620 separate fasting lipid profiles were analyzed. Calculated LDL was derived using FF and directly measured using homogenous assay using liquid selective detergent (REF 1E31-20 Multigent®). The TG values were divided into five strata (<100-I, 101-150-II, 151-200-III, 201-400-IV, and >401-V), HDL values were divided into three strata (<40-a, 40-60-b, >60-c), and LDL was stratified into five levels (<70-i; 70-99-ii; 100-130-iii; 131-160-iv; and >160-v). Distribution of LDL and concordance between LDL strata was compared between directly measured LDL and that estimated by FF.
Statistical analysis used
Continuous variables were expressed as mean and standard deviation. Correlation between the LDL by FF and direct measurement was calculated using Pearson's correlation and means were compared using paired Student's t-test.
| Results | | |
Patients were 51 ± 16 years of age and evenly distributed by sex (56% men). Patients with TG >400 (n = 228) were excluded from subsequent analysis. The median (interquartile range) TC was 176 (149-205), TG was 123 (90-169), and HDL was 42 (36-49). The median (interquartile range (IQR)) LDL calculated by FF was 105.5 (81.4-131.2) and that by direct method was 95 (74-116) mg/dl. Correlation coefficient (r) between measured LDL and FF calculated LDL was 0.89 (P < 0.001) and highest correlation was seen in TG strata II (r = 0.90).
The median (interquartile range) difference between LDL by FF and directly measured LDL was 14.8 (3.6-23.2) in TG strata I (n = 4600), 12.2 (0.15-22.2) in TG strata II (n = 7562), 6.2 (-7.6 to 18.4) in TG strata III (n = 1807), and 0.4 (-12.4 to 14.4) (n = 423) on TG strata IV. Higher levels of TG resulted in significant underestimation of LDL values by FF ( P < 0.001) [Figure 1]. This underestimation was more prevalent at the LDL <70 mg/dl. | Figure 1: Differences between FF calculated LDL and directly measured LDL in the y-axis against the across various strata of TGΩ and LDL¶ in the x-axis expressed as box-plots (whiskers indicating 5th-95th centile). Ω = TG strata: <100 - I, 101-150 - II, 151-200 - III, 201-400 - IV, >401 -V; ¶ = LDL strata <70 - i, 70-99 - ii, 100-130 - iii, 131-160 - iv, >160 - v
Click here to view |
HDL levels did not have an independent effect on the LDL calculated by FF ( P = 0.203). Concordance of the LDL strata between calculated and directly measured LDL across various LDL and TG strata is shown in [Table 1]. There was a more than 70% overestimation of risk strata by FF in LDL strata iv and v, while there was an underestimation of risk strata by FF in 16% of samples in LDL strata i and TG strata IV. | Table 1: Concordance (and discordance) of the LDL strata between FF and directly measured LDL across various LDL and TG strata
Click here to view |
Limitations
We did not have access to clinical characteristics of patients in our sample or clinical outcomes; treatment groupings and potential implications were inferred based on lipid profile only. It is unknown whether patients in our sample were receiving statin therapy.
| Discussion | | |
Our large laboratory database analysis has revealed important results, which explains some of the discrepancies noted in the previous studies. We found that calculated LDL by FF can underestimate LDL (in comparison to directly measured LDL) at lower levels of LDL and higher levels of TG. However, FF overestimates LDL at higher strata of LDL. Our results mirror similar conclusions reached by Martin et al., and Mora et al. [9],[10] Martin et al., looked into 1,310,440 total patients and 191,333 patients with Friedewald LDL <70 mg/dl and noted that a greater difference in the Friedewald-estimated versus directly measured LDL occurred at lower LDL and higher TG levels. They noted that if the Friedewald-estimated LDL was <70 mg/dl, the median directly measured LDL was 9.0 mg/dl higher (5 th -95 th percentiles, 1.8-15.4 mg/dl) when TG levels were 150-199 mg/dl and 18.4 mg/dl higher (5 th -95 th percentiles, 6.6-36.0 mg/dl) when TG levels were 200-399 mg/dl. [9] Mora et al., in their prospective study of 27,331 initially healthy women, noted that mean direct LDL was lower by approximately 5-10 mg/dl compared with Friedewald LDL. [10] While all the samples in our study were collected in the fasting state, Mora et al., showed that 21% of patients were classified into a lower-risk category by direct LDL measured in the non-fasting state.
The result of the current study becomes clinically relevant in two ways. Patients who have their LDL underestimated may lead to delay in initiation of adequate lipid-lowering therapy in high-risk patients as the practitioner is led to believe that the calculated LDL is indeed low, when it is not. On the other hand, when LDL is overestimated at higher levels, placing the patient in a higher risk strata, it results in unnecessary pharmacological therapy. Rechecking the LDL by standardized, direct assay techniques, particularly in patients with TG >200 and LDL <70 or >130 can correctly stratify the risk.
| Conclusions | | |
FF correlated with directly measured LDL with correlation coefficient of 0.89 with the best correlation seen in TG levels 100-150. Higher levels of TG (>200) underestimates the LDL by FF particularly at LDL <70. On the other hand, LDL is overestimated by FF in more than 70% of cases at LDL levels >130 mg/dl. We suggest repeating the LDL by direct assay techniques particularly in patients with TG >200 and when LDL <70 or >130. This helps in correctly stratifying the CAD risk and goals of treatment.
| Acknowledgment | | |
We sincerely acknowledge Dr Anita Suryanarayanan, Dr Monika Prabhakar, and Ms Kavitha of the Lister Metropolis Lab for their help in procuring data and helping us in the discussions.
| References | | |
| 1. | Keevil JG, Cullen MW, Gangnon R, McBride PE, Stein JH. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: Data from National Health and Nutrition Examination Survey 1999 to 2002. Circulation 2007;115:1363-70. 
|
| 2. | Roberts WC. The Friedewald-Levy-Fredrickson formula for calculating low-density lipoprotein cholesterol, the basis for lipid-lowering therapy. Am J Cardiol 1988;62:345-6.
[PUBMED] |
| 3. | Sibal L, Neely RD, Jones A, Home PD. Friedewald equation underestimates low-density lipoprotein cholesterol at low concentrations in young people with and without Type 1 diabetes. Diabet Med 2010;27:37-45.
|
| 4. | Scharnagl H, Nauck M, Wieland H, Marz W. The Friedewald formula underestimates LDL cholesterol at low concentrations. Clin Chem Lab Med 2001;39:426-31.
|
| 5. | Jun KR, Park HI, Chun S, Park H, Min WK. Effects of total cholesterol and triglyceride on the percentage difference between the low-density lipoprotein cholesterol concentration measured directly and calculated using the Friedewald formula. Clin Chem Lab Med 2008;46:371-5.
|
| 6. | Sahu S, Chawla R, Uppal B. Comparison of two methods of estimation of low density lipoprotein cholesterol, the direct versus friedewald estimation. Indian J Clin Biochem 2005;20:54-61.
|
| 7. | Gupta S, Verma M, Singh K. Does LDL-C Estimation using anandaraja's formula give a better agreement with direct LDL-C estimation than the friedewald's formula? Indian J Clin Biochem 2012;27:127-33.
|
| 8. | Anandaraja S, Narang R, Godeswar R, Laksmy R, Talwar KK. Low-density lipoprotein cholesterol estimation by a new formula in Indian population. Int J Cardiol 2005;102:117-20.
|
| 9. | Martin SS, Blaha MJ, Elshazly MB, Brinton EA, Toth PP, McEvoy JW, et al. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. J Am Coll Cardiol 2013;62:732-9.
|
| 10. | Mora S, Rifai N, Buring JE, Ridker PM. Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. Clin Chem 2009;55:888-94.
|
[Figure 1]
[Table 1]
| This article has been cited by | | 1 |
Association of SRB1 and PON1 gene polymorphisms with type 2 diabetes mellitus: a case control study |
|
| Mohd Wamique,Wahid Ali,Dandu Himanshu | | International Journal of Diabetes in Developing Countries. 2020; | | [Pubmed] | [DOI] | | | 2 |
Association of HDL-Cholesterol Level and ApoB/ApoA Ratio with Coronary Artery Disease Severity and Type 2 Diabetes Mellitus |
|
| Philips Abraham,Sachu Philip | | Journal of Evolution of Medical and Dental Sciences. 2020; 9(25): 1849 | | [Pubmed] | [DOI] | | | 3 |
Comparison of different equations for estimation of low-density lipoprotein (LDL) – cholesterol |
|
| Mehmet Fatih Alpdemir,Medine Alpdemir | | Turkish Journal of Biochemistry. 2020; 0(0) | | [Pubmed] | [DOI] | | | 4 |
Ameliorative activity of Adansonia digitata fruit on high sugar/high fat diet-simulated Metabolic Syndrome model in male Wistar rats |
|
| Hayat Mohamed Suliman,Bashier Osman,Iman H. Abdoon,Amir Mustafa Saad,Hassan Khalid | | Biomedicine & Pharmacotherapy. 2020; 125: 109968 | | [Pubmed] | [DOI] | | | 5 |
Association of Selenoprotein S Expression and its Variants with Metabolic Syndrome in Subjects with Cardiovascular Disease |
|
| Mojgan Gharipour,Mehrdad Behmanesh,Mansoor Salehi,Golnaz Vaseghi,Pouya Nezafati,Minoo Dianatkhah,Elham Khosravi,Mohsen Hosseini,Masoumeh Sadeghi | | Archives of Medical Research. 2020; | | [Pubmed] | [DOI] | | | 6 |
Evaluation of eight formulas for LDL-C estimation in Iranian subjects with different metabolic health statuses |
|
| Azam Karkhaneh,Molood Bagherieh,Solmaz Sadeghi,Asma Kheirollahi | | Lipids in Health and Disease. 2019; 18(1) | | [Pubmed] | [DOI] | | | 7 |
Effect of single nucleotide polymorphisms in SEPS1 and SEPP1 on expression in the protein level in metabolic syndrome in subjects with cardiovascular disease |
|
| Mojgan Gharipour,Khadija Ouguerram,El-Hassane Nazih,Mansoor Salehi,Mehrdad Behmanesh,Rouzbeh Razavi,Amin Gharipour,Minoo Diantkhah,Masoumeh Sadeghi | | Molecular Biology Reports. 2019; | | [Pubmed] | [DOI] | | | 8 |
Early testing of insulin resistance: a tale of two lipid ratios in a group of 5th graders screened by the Coronary Artery Risk Detection in Appalachian Communities Project (CARDIAC Project) |
|
| Charles Ituka Mosimah,Christa Lilly,Awung-Njia Forbin,Pamela J. Murray,Lee Pyles,Elloise Elliot,William Neal | | World Journal of Pediatrics. 2019; | | [Pubmed] | [DOI] | | | 9 |
Association of cholesteryl ester transferyl protein gene (G277A) polymorphism and risk prediction of type 2 diabetes mellitus: A case control study of Northern Indian population |
|
| Mohd Wamique,Wahid Ali,D. Himanshu Reddy,Mohammad Waseem,Preeti Vishwakarma | | Meta Gene. 2018; 17: 163 | | [Pubmed] | [DOI] | | | 10 |
Strategy for Early Identification of Prediabetes in Lean Populations: New Insight from a Prospective Chinese Twin Cohort of Children and Young Adults |
|
| Guoying Wang,Sally Radovick,Xiping Xu,Houxun Xing,Genfu Tang,Tami R. Bartell,Binyan Wang,Xiaobin Wang | | Diabetes Research and Clinical Practice. 2018; | | [Pubmed] | [DOI] | | | 11 |
ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels |
|
| Ji Eun Jun,Young Ju Choi,Yong-Ho Lee,Dae Jung Kim,Seok Won Park,Byung Wook Huh,Eun Jig Lee,Sun-Ha Jee,Kyu Yeon Hur,Sung Hee Choi,Kap Bum Huh | | The Korean Journal of Internal Medicine. 2018; 33(1): 138 | | [Pubmed] | [DOI] | | | 12 |
Which of low-density lipoprotein cholesterol estimates can be used in children with type 1 diabetes? |
|
| Jolanta Bugajska,Joanna Berska,Katarzyna Mamica,Karolina Wachacka,Krystyna Sztefko | | Diagnosis. 2017; 4(1): 43 | | [Pubmed] | [DOI] | | | 13 |
Calculated low density lipoprotein cholesterol: Its relevance in Indian perspective |
|
| Prabhat Kumar Nigam | | Indian Heart Journal. 2017; | | [Pubmed] | [DOI] | | | 14 |
Comparing calculated LDL-C with directly measured LDL-C in healthy and in dyslipidemic children |
|
| Anastasia Garoufi,Antonis Drakatos,Charalampos Tsentidis,Eleni Klinaki,Irene Paraskakis,Antonios Marmarinos,Dimitrios Gourgiotis | | Clinical Biochemistry. 2016; | | [Pubmed] | [DOI] | |
|
 |
|
|
|
